logo
Scotch meets match; local Single Malts win hearts

Scotch meets match; local Single Malts win hearts

Economic Times01-06-2025
More Indians are raising a toast to home-grown single malt whisky than ever before, reflected in rising sales of local brands, overshadowing the long-desired single malt Scotch. For the first time, among single malts, Indian whisky outsold Scotch in 2024. This was helped by increasing affinity for local premium malts even as sales of the Scotch fell. "After advancing by more than 75% in 2023, annual sales of Indian single malts came within 9,000 nine-litre cases of surpassing sales of single malt Scotch,' said alcohol market researcher IWSR. 'With a further advance in sales of more than 25% in 2024, Indian single malts significantly outsold their Scotch counterparts." IWSR did not divulge share sales performance data for individual Indian or Scottish single malts in the country. 'Sales of single malt Scotch fell back in 2024, further than they did in 2020, during the pandemic, and while the category remains aspirational, it seems many consumers have transferred at least some of their interest to Indian single malts,' it said. Single malt refers to whisky from one distillery—prized for its unique taste—as opposed to a blend of whiskies. Amrut and Paul John were the first Indian single malt brands, launched in the 2000s. However, in the past three years, the market saw a flurry of new single malt distillers, including Piccadily Agro—which launched Indri and Kamet — and the likes of Radico Khaitan with its Rampur single malt.
Global liquor companies such as Pernod Ricard and Diageo are also adding their own Indian brands such as Longitude 77 and Godawan.
'Consumers don't shy away from stocking Indian single malts, along with other world whiskies, as the product quality, packaging and price is at par or even better than imported ones. The trend is similar to how Japanese malts gained popularity a few years ago," said Rakshit Jagdale, managing director, Amrut Distilleries. "Indian malts are also riding the wave of increased sense of nationalism and pride where they no longer perceive Scotch to be better than Indian single malts." For decades, the success of single malt whisky has been closely tied to perceptions about age, quality and price—the older the better, and more expensive. Indian single malts don't carry age statements because of local climatic conditions. In Scotland, for instance, the evaporation during barrel ageing—known as the angels' share—is just 2-3% a year, while in the heat of India, it is commonly more than 10%. Most Indian single malts, therefore, have an optimum maturation of five to eight years. "Indian single malts are progressively contributing to the expansion of the overall single malt segment. This will further enable faster transition for even more consumers to upgrade to single malt scotch brands like Glenfiddich and The Balvenie,' said Sachin Mehta, country director, India, and Indian subcontinent at William Grant & Sons.
NEW NAMES
With more than a dozen new Indian single malt brands entering the market, the initial numbers reflect sales to the channel and not end user consumption, note experts. These brands also offer a wider choice and availability in retail stores, as well as the advantage of sales through the defence ministry's Canteen Stores Department, where the sale of imported brands is barred. While the current strong consumer interest in Indian single malts is expected to sustain, growth momentum may be impacted by availability. Investments made in the last two years in whisky production will take at least five years to yield mature whisky.
Paul John, founder of John Distillers, said many companies are currently scrambling to launch single malts. "We have an advantage and a great start as far as the single malt is concerned with products which cater from newcomers to seasoned connoisseurs. The launch of multiple expressions with clear differentiation in liquid profiles supports our portfolio's appeal,' he said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Higher US tariffs may trim India's GDP growth by 30 bps: Barclays
Higher US tariffs may trim India's GDP growth by 30 bps: Barclays

Business Standard

time6 minutes ago

  • Business Standard

Higher US tariffs may trim India's GDP growth by 30 bps: Barclays

The 25 per cent US tariffs, plus a penalty for Russian imports, could dent India's GDP growth by 30 basis points in the current fiscal, but the higher duty is unlikely to significantly affect India's domestic demand-driven economy, Barclays said on Thursday. If the 25 per cent tariff, announced by US President Donald Trump on Wednesday, is implemented from August 1, the effective average US import tariff on Indian goods will rise to 20.6 per cent in trade-weighted terms, as per Barclays estimates. This is sharply higher than both the pre 'liberation day' tariff rate of 2.7 per cent and the 90-day pause tariff rate of 11.6 per cent. In contrast, India's import tariff on US goods is lower, at 11.6 per cent in trade-weighted terms. Barclays said that given the relatively closed nature of the Indian economy, wherein domestic demand is the mainstay of growth. "We do not see this 25 per cent tariff threat impacting GDP growth meaningfully, pegging the likely impact at 30 bp. We expect final tariffs on India to settle in lower than the announced 25 per cent, as India and the US continue with trade deal talks," it said. Indian economy is projected to grow at 6.5 per cent by the Reserve Bank-- same as last fiscal, while the International Monetary Fund (IMF) and Asian Development Bank (ADB) peg growth at 6.4 per cent and 6.5 per cent respectively. At 25 per cent, tariffs on India are higher than EM Asian peers, but Barclays expect final tariffs to settle lower as trade deal talks progress. Echoing similar views, Moody's Analytics Associate Economist Aditi Raman said while the US is India's largest trade partner, the Indian economy is relatively more domestically oriented than most of the region and relies far less on trade. "Pharmaceuticals, gems, and textiles are key sectors that are likely to be hit. A point of contention is market access to the key agricultural and dairy sector, which India has historically been reluctant to grant," Raman said. Barclays further said, India is already diversifying its sources of oil supply. Should the additional 'penalty' threat materialise, we expect Indian refiners to pivot towards alternate suppliers, especially as the discount on imports of Russian oil has already narrowed. To diversify its export base, the Indian administration is showcasing a renewed zeal to ink free-trade agreements with other countries and regions. "Amid heightened global trade policy uncertainty, having a pipeline of such bilateral trade agreements is a prudent policy choice," Barclays said. India has recently inked an FTA with the US and the EFTA bloc, and it is negotiating with a number of countries, including the European Union, Oman and New Zealand. The US is India's largest trading partner, accounting for 18 per cent of India's total merchandise exports in 2024. India's USD 80 billion merchandise exports to the US are distributed in sectors which also form India's overall major exports. India's top exports to the US, electrical machinery (USD 12 billion, including smartphones), and gems and jewellery (USD 9 billion) now face tariff increases of just over 24 percentage points, compared with levels before April 2. On the rupee, Barclays said that although more pain is expected in the near term, the drop in INR vis--vis USD still looks overdone. The INR, which had already been under pressure over recent weeks, fell sharply on the tariff news, hitting a low weaker than 87.50 versus USD. "We think the rupee is looking oversold in the short term. Clearly, USDINR has bounced more than anticipated, but we think the February high of just under 88.0 remains a strong resistance level," Barclays said.

Nagaraj Shetti suggests Alkyl Amines, Star Health shares to buy in the short term; do you own?
Nagaraj Shetti suggests Alkyl Amines, Star Health shares to buy in the short term; do you own?

Mint

time6 minutes ago

  • Mint

Nagaraj Shetti suggests Alkyl Amines, Star Health shares to buy in the short term; do you own?

Stock market today: Indian stock markets reduced their initial declines on Thursday as investors perceived the US threat of a 25% tariff and unspecified penalties, set to take effect on August 1, more as a bargaining strategy than a definitive action. As of 11:40 IST, the Nifty 50 was down 0.26% at 24,791.45 points, while the BSE Sensex fell 0.28% to 81,259.37. Both indices had dropped approximately 0.9% during early trading. Following the tariff announcement, President Donald Trump indicated that the US is still in trade negotiations with India. The proposed 25% tariff on Indian imports, along with a penalty related to energy and defense agreements with Russia, poses a clear short-term threat to exports and GDP growth, according to three analysts. As per Nagaraj Shetti from HDFC Securities, any additional decline in the Nifty 50 may encounter significant support between the 24,600 and 24,500 levels in the upcoming sessions. Shetti recommends two stocks to buy in the short-term. Here's what Shetti says about the overall market. After showing a narrow range movement on Wednesday, Nifty 50 slipped into sharp weakness on Thursday on the backdrop of US President Trump's announcement of 25% tariff and penalty on the trade deal with India and the Nifty 50 is now trading lower by 100 amidst recovery from the lows. The recent bullish pattern like bullish engulfing is still intact and Nifty 50 seems to have taken support of 24,600 for the short-term. Further weakness from here could find strong support around 24,600-24,500 levels in the coming sessions. Immediate hurdle to be watched around 24,900. Nagaraj Shetti of HDFC Securities recommends these two stocks to buy in the short-term - Alkyl Amines Chemicals Ltd, and Star Health and Allied Insurance Company Ltd. After showing a reasonable downward correction in last week, the stock price has witnessed sharp upmove so far this week. The stock price has broken above the hurdle of down sloping trend line at ₹ 2,250 and is trading higher. Volume and RSI pattern shows positive indication. The range bound movement of the last few weeks seems to be ending now for this health insurance stock. The stock is currently placed at the edge of upside breakout of 200day EMA at ₹ 448-450 levels. Bullish pattern like higher highs and lows is intact. Daily RSI shows positive indication. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before taking any investment decisions.

Nifty 50 tends to gain in August, shows 10-year history. Can the trend sustain amid Trump's tariff curveball?
Nifty 50 tends to gain in August, shows 10-year history. Can the trend sustain amid Trump's tariff curveball?

Mint

time6 minutes ago

  • Mint

Nifty 50 tends to gain in August, shows 10-year history. Can the trend sustain amid Trump's tariff curveball?

Indian stock market: Benchmark indices paused for breath in July after a stellar multi-month rally, as disappointing corporate earnings and persistent foreign outflows weighed on sentiment. Investor caution was further heightened by uncertainty around a potential trade deal, which ultimately failed to meet expectations. US President Donald Trump threw a curveball in the form of a 25% tariff on imports, along with a warning of unspecified penalties for energy and defence-related purchases from Russia. This promoted worries that August, which is generally a positive month for the Indian stock market, may see tempered gains as global headwinds and cautious investor sentiment persist. Historically, July and August are among the most seasonally positive months for Indian equities. The Nifty 50 index has shown a positive trend during the month of August, delivering gains in six out of the past 10 years, according to data from JM Financial, with a median return of 1.4%. While markets bucked the trend in July, declining 1.7% so far (till July 30), analysts believe that while August may be characterised by volatility, it is likely to exhibit a positive trend. Harshal Dasani, Business Head, INVasset PMS, said that August could present a turnaround. With the ambiguity around the US–India trade stance gradually resolving — even if via an adverse outcome like tariff escalation — the market may begin to stabilise, Dasani said, adding that historically, equities consolidate when the 'event risk' transitions into known outcomes. Ashish Chaturmohta, Managing Director & Fund Manager, Apex PMS, JM Financial, also opined that despite some weakness in July 2025, primarily due to a softer outlook from the IT sector and elevated provisioning in the BFSI segment, the outlook for August remains constructive. His optimism is supported by above-average monsoon rainfall and improved reservoir levels, which are expected to boost rural demand and support agriculture, and a decent earnings season. "External environment, particularly the US tariff on Indian exports, remains the key monitorable and could influence market sentiments. Overall, the market sentiment for August 2025 appears positive and aligned with historical averages," said Chaturmohta. While analysts foresee an impact of Trump's tariff threat on export-heavy sectors, barring a full-blown trade war, they see limited downside. Emkay Global, in a note today, said that although trade talks appear to have stalled, we believe this saga is far from over. "Beyond pure economics, such negotiations carry significant geopolitical weight. Despite a potential shift in the balance of negotiation power, we believe both sides are still likely to push for a deal soon," it said. India's exports to the US are only 2% of GDP, with much lower value-added embedded in them. According to Emkay's estimates, previous static analysis suggests that India's US exports could drop by $30-33 bn (0.8-0.9% of GDP) at 25%+ tariffs, not adjusting for the complexity of dynamic cross-country hits/responses. While the announcement adds some downside tail risk, it is too early to consider actual forecast changes, it added. "In fact, with the rupee stabilising near ₹ 87.5 and Brent crude easing below $73, key macro stressors seem priced in. The geopolitical risk premium is also no longer expanding. Given that the uncertainty has peaked, and past Augusts tend to favour bulls, we could now see a shift from risk-off to recalibration mode—especially if global yields cool," Dasani added. As the market is expected to be volatile amid event-driven swings, Khushi Mistry, Research Analyst at Bonanza, advised adopting a cautious and selective approach. "It is prudent to emphasise quality large-cap companies with strong balance sheets and steady domestic demand exposure, such as financials and consumption sectors, rather than chasing risky small and midcap stocks." Gradual accumulation on market dips can capture value while maintaining discipline, Mistry recommended. Jashan Arora, Director at Master Trust Group, also advised investors to stay selectively invested, focusing on quality large-caps and sectors like banking, capital goods, and auto. "Caution is advised in small caps. A staggered approach to investing may help navigate any near-term volatility." Major drivers for August could include global interest rate signals, crude oil prices, domestic inflation and GDP data, and any geopolitical developments, along with FII stance, added Arora. Disclaimer: This story is for educational purposes only. The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store